Baidu
map

Nature:科学家发现了干预肺癌恶化的关键所在

2017-05-12 枫丹白露 来宝网

被称为腺瘤的良性肿瘤——肺腺癌是占美国肺癌病例约40%的侵袭性癌症。麻省理工学院生物学家现在确定了一种主要的转变,发生在腺瘤转移成腺癌的肺癌小鼠模型中。他们还发现阻止这种切换可以防止肿瘤变得更具攻击性。研究人员说,干扰这种转换的药物因此可用于治疗早期肺癌。

被称为腺瘤的良性肿瘤——肺腺癌是占美国肺癌病例约40%的侵袭性癌症。

麻省理工学院生物学家现在确定了一种主要的转变,发生在腺瘤转移成腺癌的肺癌小鼠模型中。他们还发现阻止这种切换可以防止肿瘤变得更具攻击性。研究人员说,干扰这种转换的药物因此可用于治疗早期肺癌

麻省理工学院院长泰勒·杰克斯(Tyler Jacks)说:“了解作为肿瘤从良性状态转变为恶性肿瘤的分子途径对于治疗具有重要意义,这些研究结果还提出了预防或干扰晚期疾病发病的方法。”

当肿瘤中的一小部分细胞开始像干细胞一样起作用,从而使它们产生无限的新型癌细胞群体时,即发生转换。

“似乎干细胞是肿瘤生长的引擎,它们具有非常强大的增殖潜力,并且产生其他癌细胞,也产生更多的干细胞,”Tuomas Tammela博士说。

肿瘤干细胞

在这项研究中,研究人员将研究集中在称为Wnt的细胞信号通路的作用上。这种途径通常仅在胚胎发育过程中开启,但它也可以在能够再生特定组织如肠内衬的成体干细胞的小群体中起作用。

Wnt途径的主要作用之一是将细胞维持在干细胞状态,所以麻省理工学院的团队怀疑Wnt可能参与早期肿瘤成为腺癌时发生的快速增殖。

研究人员在基因编程的小鼠中探索了这个问题。在这些小鼠中,他们发现Wnt信号在腺瘤中无活性,但在转化期间,约5%至10%的肿瘤细胞导致Wnt通路激活。然后,这些细胞作为新的癌细胞的无尽池。

此外,大约30%至40%的肿瘤细胞开始产生化学信号,从而产生“利基”,这是维持细胞处于干细胞样状态所必需的局部环境。

“如果你把干细胞从这个微环境中拿出来,它会迅速失去其干细胞的性质,”Tammela说。 “您有一种形成利基的细胞类型,然后您有另一种细胞类型接收利基线索,并且像干细胞一样作用。”

虽然已经发现Wnt在一些其他癌症(包括结肠癌)中驱动肿瘤形成,但该研究指出了其在肺癌和可能的其他癌症如胰腺癌中的新型作用。

“这个发现的新特点是,该途径不是一个驱动因素,而是改变癌细胞的特征,它定性地改变了癌细胞行为的方式,”Tammela说。

针对Wnt

当研究人员给小鼠一种干扰Wnt蛋白质的药物时,他们发现肿瘤停止生长,小鼠寿命增加了50%。此外,当将这些处理的肿瘤细胞植入另一动物时,它们不能产生新的肿瘤。

研究人员还分析了人肺腺癌样本,发现70%的肿瘤显示出Wnt活化,80%的肿瘤具有刺激Wnt活性的细菌环境。研究人员说,这些研究结果表明,在早期肺癌患者中测试Wnt抑制剂是值得的。

他们还在努力以更有针对性的方式提供Wnt抑制剂,以避免药物引起的一些副作用。避免副作用的另一种可能的方法可能是开发更特异性的抑制剂,其仅靶向针对在肺腺癌中有活性的Wnt蛋白质。研究人员在本研究中使用的Wnt抑制剂,目前正在临床试验中治疗其他类型的癌症,靶向针对所有19种Wnt蛋白。

原始出处:

Tuomas Tammela, et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature (2017) doi:10.1038/nature22334.Published online 10 May 2017

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1802415, encodeId=0b09180241515, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Dec 03 22:03:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882022, encodeId=e505188202266, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 20 23:03:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198282, encodeId=e278198282b6, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon May 15 08:46:37 CST 2017, time=2017-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197691, encodeId=f9ca19e691d5, content=学习了,Wnt信号通路,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat May 13 23:17:53 CST 2017, time=2017-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197150, encodeId=f49919e1509f, content=早日应用于临床,解救痛苦中的肺癌晚期患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 12 15:20:35 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197135, encodeId=ba3a19e13565, content=wnt蛋白在肿瘤领域很热门, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhbPwBo0yCebU4qpdSwzpBA1WFXMEUicoTnJDickpj9Ve1cUdNjjTiaDXmpXL47LYh3DdYkPOA2kddyZ/0, createdBy=508c2054450, createdName=solarjin, createdTime=Fri May 12 14:35:20 CST 2017, time=2017-05-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1802415, encodeId=0b09180241515, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Dec 03 22:03:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882022, encodeId=e505188202266, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 20 23:03:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198282, encodeId=e278198282b6, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon May 15 08:46:37 CST 2017, time=2017-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197691, encodeId=f9ca19e691d5, content=学习了,Wnt信号通路,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat May 13 23:17:53 CST 2017, time=2017-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197150, encodeId=f49919e1509f, content=早日应用于临床,解救痛苦中的肺癌晚期患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 12 15:20:35 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197135, encodeId=ba3a19e13565, content=wnt蛋白在肿瘤领域很热门, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhbPwBo0yCebU4qpdSwzpBA1WFXMEUicoTnJDickpj9Ve1cUdNjjTiaDXmpXL47LYh3DdYkPOA2kddyZ/0, createdBy=508c2054450, createdName=solarjin, createdTime=Fri May 12 14:35:20 CST 2017, time=2017-05-12, status=1, ipAttribution=)]
    2018-02-20 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1802415, encodeId=0b09180241515, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Dec 03 22:03:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882022, encodeId=e505188202266, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 20 23:03:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198282, encodeId=e278198282b6, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon May 15 08:46:37 CST 2017, time=2017-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197691, encodeId=f9ca19e691d5, content=学习了,Wnt信号通路,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat May 13 23:17:53 CST 2017, time=2017-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197150, encodeId=f49919e1509f, content=早日应用于临床,解救痛苦中的肺癌晚期患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 12 15:20:35 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197135, encodeId=ba3a19e13565, content=wnt蛋白在肿瘤领域很热门, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhbPwBo0yCebU4qpdSwzpBA1WFXMEUicoTnJDickpj9Ve1cUdNjjTiaDXmpXL47LYh3DdYkPOA2kddyZ/0, createdBy=508c2054450, createdName=solarjin, createdTime=Fri May 12 14:35:20 CST 2017, time=2017-05-12, status=1, ipAttribution=)]
    2017-05-15 flysky120

    学习一下知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1802415, encodeId=0b09180241515, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Dec 03 22:03:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882022, encodeId=e505188202266, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 20 23:03:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198282, encodeId=e278198282b6, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon May 15 08:46:37 CST 2017, time=2017-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197691, encodeId=f9ca19e691d5, content=学习了,Wnt信号通路,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat May 13 23:17:53 CST 2017, time=2017-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197150, encodeId=f49919e1509f, content=早日应用于临床,解救痛苦中的肺癌晚期患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 12 15:20:35 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197135, encodeId=ba3a19e13565, content=wnt蛋白在肿瘤领域很热门, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhbPwBo0yCebU4qpdSwzpBA1WFXMEUicoTnJDickpj9Ve1cUdNjjTiaDXmpXL47LYh3DdYkPOA2kddyZ/0, createdBy=508c2054450, createdName=solarjin, createdTime=Fri May 12 14:35:20 CST 2017, time=2017-05-12, status=1, ipAttribution=)]
    2017-05-13 luominglian113

    学习了,Wnt信号通路,谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1802415, encodeId=0b09180241515, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Dec 03 22:03:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882022, encodeId=e505188202266, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 20 23:03:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198282, encodeId=e278198282b6, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon May 15 08:46:37 CST 2017, time=2017-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197691, encodeId=f9ca19e691d5, content=学习了,Wnt信号通路,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat May 13 23:17:53 CST 2017, time=2017-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197150, encodeId=f49919e1509f, content=早日应用于临床,解救痛苦中的肺癌晚期患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 12 15:20:35 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197135, encodeId=ba3a19e13565, content=wnt蛋白在肿瘤领域很热门, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhbPwBo0yCebU4qpdSwzpBA1WFXMEUicoTnJDickpj9Ve1cUdNjjTiaDXmpXL47LYh3DdYkPOA2kddyZ/0, createdBy=508c2054450, createdName=solarjin, createdTime=Fri May 12 14:35:20 CST 2017, time=2017-05-12, status=1, ipAttribution=)]
    2017-05-12 有备才能无患

    早日应用于临床,解救痛苦中的肺癌晚期患者

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1802415, encodeId=0b09180241515, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Dec 03 22:03:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882022, encodeId=e505188202266, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 20 23:03:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198282, encodeId=e278198282b6, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon May 15 08:46:37 CST 2017, time=2017-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197691, encodeId=f9ca19e691d5, content=学习了,Wnt信号通路,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat May 13 23:17:53 CST 2017, time=2017-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197150, encodeId=f49919e1509f, content=早日应用于临床,解救痛苦中的肺癌晚期患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 12 15:20:35 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=197135, encodeId=ba3a19e13565, content=wnt蛋白在肿瘤领域很热门, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhbPwBo0yCebU4qpdSwzpBA1WFXMEUicoTnJDickpj9Ve1cUdNjjTiaDXmpXL47LYh3DdYkPOA2kddyZ/0, createdBy=508c2054450, createdName=solarjin, createdTime=Fri May 12 14:35:20 CST 2017, time=2017-05-12, status=1, ipAttribution=)]
    2017-05-12 solarjin

    wnt蛋白在肿瘤领域很热门

    0

相关资讯

Eur J Cancer:高水平超敏C反应蛋白在肺癌患者中的影响的研究进展

许多文献报道,血中高水平的超敏C反应蛋白(CRP)是导致心血管疾病、慢性阻塞性肺疾病、癌症等患者生存期缩短的原因之一。在Eur J Cancer杂志上的一篇文章报道,研究者对可行手术治疗的肺癌患者,其血中CPR基线及术后水平的影响进行了调查研究。该研究对象为2003到2015年期间1750名肺癌全切术的患者,测量其基线水平的CRP水平,及术后3天的CRP水平。按照0个危险因素(N=593)、1个危

Lancet:头碰头一线ALK阳性非小细胞肺癌治疗艾乐替尼vs克唑替尼

头碰头一线ALK阳性非小细胞肺癌治疗研究中,艾乐替尼组的试验剂量低于其日本以外地区的批准剂量,但效果较克唑替尼更为显著

肺癌适合靶向药吗?新型血检3天内出结果

非小细胞肺癌(NSCLC)发病相关的关键驱动基因变异,已经找到了不下10种,并且,针对这些基因异常,已经研制了许多低毒高效的高度特异性靶向药。由于这些靶向药与基因变异的关系,好比一把钥匙开一把锁,所以,肺癌基因精准检测,是确保患者能够合理选用最佳靶向药的关键前提。基因检测怎么做?大多数的肺癌患者,通常会接受侵袭性组织活检(直接取下鲜活肿瘤组织样本送检)。这样的有创性活检,有两大缺憾:一方面

安贞医院年轻医生“肺癌晚期”:上天留我吧!

上天留我吧!对这个世界还有很多依恋…… 作者 | 阿迪 来源 | "说癌"微信号 作为北京安贞医院小儿心脏外科的主刀大夫,赵涛从本科到博士后学医从医十多年,曾帮无数病人击败过病魔。但不曾想到的是,他自己却倒在了病魔的面前:2016年6月他被诊断为肺癌晚期。 “春节后感冒发烧一个多月,又从鬼门关前走了一遭……”,刚出院不久的赵涛坐在我面前弱弱地说。身体虚弱,脸浮肿着——激素药物的副作用显

梳理CAR-T细胞疗法研究新近进展

CAR-T(Chimeric Antigen Receptor T-Cell Immunotherapy),即嵌合抗原受体T细胞免疫疗法。该疗法是一种出现了很多年但近几年才被改良使用到临床中的新型细胞疗法。在急性白血病和非霍奇金淋巴瘤的治疗上有着显著的疗效,被认为是最有前景的肿瘤治疗方式之一。正如所有的技术一样,CAR-T技术也经历一个漫长的

聚焦精准医疗:臻和“全程全面管理”模式,有望为肺癌治疗带来新突破

2017年5月7日太原—鉴于近年来中国肺癌高发的严峻形势,旨在探索肺癌“全程全面管理”新模式的一场题为“聚焦ctDNA,开启肿瘤精准治疗”高峰论坛在太原拉开帷幕,该会议由致力精准医疗的臻和科技主办,汇聚了包括同济大学附属上海肺科医院周彩存教授和上海交通大学医学院附属瑞金医院张俊教授及来自全国众多的知名专家学者和教授的积极参与。臻和科技首席医学官张恒辉博士发言论坛上,臻和科技首席医院官张恒辉博士提出

Baidu
map
Baidu
map
Baidu
map